Filter
59
Text search:
dolutegravir
Featured
Recommendations
9
New Publications
10
Language
Document type
Guidelines
18
No document type
18
Studies & Reports
16
Manuals
4
Strategic & Response Plan
3
Countries / Regions
South Africa
2
South–East Asia Region
2
Ethiopia
1
Philippines
1
Rwanda
1
Argentina
1
Brazil
1
Lesotho
1
Western Pacific Region
1
Latin America and the Carribbean
1
Africa
1
Global
1
Authors & Publishers
Publication Years
Category
Countries
10
Clinical Guidelines
7
Women & Child Health
1
Key Resources
1
Toolboxes
HIV
40
TB
5
Pharmacy
4
COVID-19
3
Conflict
1
Mental Health
1
AMR
1
WHO’s sentinel surveys of acquired HIV resistance to dolutegravir among people receiving dolutegravir-containing antiretroviral therapy is intended for easy and frequent implementation. Results fr
...
This technical report summarizes the discussions on the status of programmatic transition to tenofovir, lamivudine and dolutegravir (TLD) in low– and middle- income countries, addressing the best practices and major challenges faced by HIV program
...
Avec l’essor des traitements antirétroviraux (TAR) à base de dolutégravir (DTG) pour soigner les personnes vivant avec le VIH dans le monde, il est important d’estimer la vitesse à laquelle la résistance acquise au DTG apparaît dans les po
...
Em meados de 2021, os programas nacionais de SIDA começaram a fazer a transição do tratamento para crianças que vivem com VIH dolutegravir (DTG) 10 mg sulcado, comprimidos dispersíveis, também conhecido como DTG pediátrico (pDTG). A rápida i
...
Medicines and medical devices for 10 000 people for approximately three months
الأدوية الأساسية
recommended
. MSF Essential Drugs Guidelines دليل عملي موجه للأطباء والصيادلة والممرضين والمساعدين الطبيين
People living with HIV depend on life-saving antiretroviral therapy (ART) and access to ART must be maintained during periods of travel restrictions and lockdowns resulting from the COVID-19 pandemic. The Information note on HIV and COVID-19 addresses common concerns people living with HIV have rega
...
La Profilaxis Post-Exposición para el VIH (PEP) constituye una herramienta de prevención que consiste en el uso de medicamentos antiretrovirales para reducir el riesgo de infección luego de situaciones de potencial exposición del virus. Su incorporación está recomendada por la Organización Mu
...
National Guidelines for HIV & AIDS Care and Treatment (5th Edition)
HIV drug resistance strategies focus on prevention through adherence and treatment optimization, surveillance to monitor resistance trends, and innovation in new drugs and diagnostics. Key approaches include implementing national action plans, strengthening laboratory capacity for monitoring, and pr
...
